10-Q/APeriod: Q1 FY2003

ECOLAB INC. Quarterly Report (Amendment) for Q1 Ended Mar 31, 2003

Filed August 8, 2003For Securities:ECL

Summary

Ecolab Inc. (ECL) reported a strong first quarter for 2003, demonstrating significant year-over-year growth. Net sales increased by 11% to $875.8 million, driven by organic growth, acquisitions, and a favorable currency translation impact. The company's profitability saw a substantial improvement, with net income rising 58% to $55.3 million, translating to a diluted EPS of $0.42, up from $0.27 in the prior year. This earnings growth was bolstered by improved gross profit margins due to product mix and cost reduction efforts, alongside effective cost controls in selling, general, and administrative expenses. Comparisons to the prior year's first quarter were impacted by significant one-time events in 2002, including restructuring charges and a curtailment gain, which skewed profitability metrics. For 2003, Ecolab is realizing cost savings from previous restructuring initiatives, with a portion being reinvested into the business to fuel growth. The company also saw increased investments in sales and service, along with higher healthcare costs. Ecolab maintained a solid financial position, with total assets increasing and a healthy debt-to-capitalization ratio.

Key Highlights

  • 1Consolidated net sales increased 11% to $875.8 million for Q1 2003 compared to Q1 2002.
  • 2Net income grew significantly by 58% to $55.3 million, with diluted EPS rising to $0.42 from $0.27.
  • 3Gross profit margin improved to 50.8% in Q1 2003 from 49.6% in Q1 2002 (50.3% excluding restructuring charges).
  • 4Selling, general, and administrative expenses as a percentage of sales increased slightly to 39.3% from 38.8%, attributed to acquisitions and investments.
  • 5The company realized $7.5 million in restructuring savings in Q1 2003, with expectations of $25-$30 million pre-tax annual savings.
  • 6Total assets increased to $3.01 billion, driven by acquisitions and currency exchange rate effects.
  • 7The company reported adopting SFAS No. 142, discontinuing amortization of goodwill and indefinite-lived intangibles, and took a $4.0 million impairment charge in Q1 2002 related to this adoption.

Frequently Asked Questions

Ecolab's net sales increased by 11% year-over-year to $875.8 million. This growth was driven by a combination of factors including organic growth from aggressive new account sales, successful new product introductions, improved service initiatives, and the positive impact of business acquisitions and favorable foreign currency translation effects.

Profitability saw a substantial improvement. Net income increased by 58% to $55.3 million, leading to a diluted EPS of $0.42, up from $0.27 in the prior year. This improvement was due to higher sales, an improved gross profit margin (50.8% vs. 49.6%), and effective cost controls. The comparison was also aided by the absence of significant one-time charges that impacted the prior year's first quarter.

Ecolab adopted SFAS No. 142 effective January 1, 2002, which discontinued the amortization of goodwill and indefinite-lived intangible assets. In the first quarter of 2002, the company recorded a non-cash impairment charge of $4.0 million related to this adoption, which negatively impacted the prior year's results. For 2003, this change means that goodwill is no longer amortized but is subject to periodic impairment testing.

In the first quarter of 2002, Ecolab incurred significant special charges totaling $23.3 million related to restructuring and cost-saving actions, including global workforce reductions and facility closings, primarily for the integration of European operations. There was also a curtailment gain of $5.8 million related to postretirement healthcare benefit changes in the same period. These significant one-time items in Q1 2002 make the year-over-year comparison of Q1 2003 results more favorable due to their absence.